105 related articles for article (PubMed ID: 23970286)
1. Diet-induced obesity promotes murine gastric cancer growth through a nampt/sirt1/c-myc positive feedback loop.
Li HJ; Che XM; Zhao W; He SC; Zhang ZL; Chen R; Fan L; Jia ZL
Oncol Rep; 2013 Nov; 30(5):2153-60. PubMed ID: 23970286
[TBL] [Abstract][Full Text] [Related]
2. Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis.
Brandl L; Zhang Y; Kirstein N; Sendelhofert A; Boos SL; Jung P; Greten F; Rad R; Menssen A
Neoplasia; 2019 Oct; 21(10):974-988. PubMed ID: 31442917
[TBL] [Abstract][Full Text] [Related]
3. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target.
Brandl L; Kirstein N; Neumann J; Sendelhofert A; Vieth M; Kirchner T; Menssen A
Med Oncol; 2018 Nov; 36(1):5. PubMed ID: 30460421
[TBL] [Abstract][Full Text] [Related]
4. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.
Menssen A; Hydbring P; Kapelle K; Vervoorts J; Diebold J; Lüscher B; Larsson LG; Hermeking H
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):E187-96. PubMed ID: 22190494
[TBL] [Abstract][Full Text] [Related]
5. Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis.
Reverchon M; Cornuau M; Cloix L; Ramé C; Guerif F; Royère D; Dupont J
Mol Hum Reprod; 2013 May; 19(5):313-26. PubMed ID: 23315983
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
[TBL] [Abstract][Full Text] [Related]
7. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide phosphoribosyltransferase delays cellular senescence by upregulating SIRT1 activity and antioxidant gene expression in mouse cells.
Khaidizar FD; Nakahata Y; Kume A; Sumizawa K; Kohno K; Matsui T; Bessho Y
Genes Cells; 2017 Dec; 22(12):982-992. PubMed ID: 29178516
[TBL] [Abstract][Full Text] [Related]
10. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.
Choi SE; Fu T; Seok S; Kim DH; Yu E; Lee KW; Kang Y; Li X; Kemper B; Kemper JK
Aging Cell; 2013 Dec; 12(6):1062-72. PubMed ID: 23834033
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.
Herranz D; Maraver A; Cañamero M; Gómez-López G; Inglada-Pérez L; Robledo M; Castelblanco E; Matias-Guiu X; Serrano M
Oncogene; 2013 Aug; 32(34):4052-6. PubMed ID: 22986535
[TBL] [Abstract][Full Text] [Related]
13. Expression of n-MYC, NAMPT and SIRT1 in Basal Cell Carcinomas and their Cells of Origin.
Brandl L; Hartmann D; Kirchner T; Menssen A
Acta Derm Venereol; 2019 Jan; 99(1):63-71. PubMed ID: 30182136
[TBL] [Abstract][Full Text] [Related]
14. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
[TBL] [Abstract][Full Text] [Related]
15. Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice.
Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
Diabetes Obes Metab; 2011 Dec; 13(12):1097-104. PubMed ID: 21733059
[TBL] [Abstract][Full Text] [Related]
16.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
17. Resveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes.
Schuster S; Penke M; Gorski T; Petzold-Quinque S; Damm G; Gebhardt R; Kiess W; Garten A
PLoS One; 2014; 9(3):e91045. PubMed ID: 24603648
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil.
Bi TQ; Che XM; Liao XH; Zhang DJ; Long HL; Li HJ; Zhao W
Oncol Rep; 2011 Nov; 26(5):1251-7. PubMed ID: 21743967
[TBL] [Abstract][Full Text] [Related]
19. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
20. Obesity accelerates murine gastric cancer growth by modulating the Sirt1/YAP pathway.
Li HJ; Fu JK; Che XM; Fan L; Zhang Y; Bai E
Oncol Lett; 2017 Oct; 14(4):4151-4157. PubMed ID: 28943922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
